Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wuji Baifeng Tablets for premature ovarian insufficiency
ChiCTR2100054952Phase 4Recruiting
- Sponsor
- Beijing Obstetrics and Gynecology Hospital
- Start
- Aug 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tongren Wuji Baifeng Pill in ovarian hypofunction (POI) (2 arms), sponsored by Beijing Obstetrics and Gynecology Hospital. Primary endpoint: Follicle-stimulating hormone. Started Aug 2019; status: recruiting.
02
Drugs
Tongren Wuji Baifeng Pill
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on ChiCTR2100054952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054952.